Or another title as suggested by our guest blogger could be… “Politicians and reporters make a stink about opioid-induced constipation”…
Xtampza; A New Oxycodone ER Option
Last week (April 26, 2016), the US Food and Drug Administration (FDA) approved Xtampza (oxycodone extended-release), a twice-daily abuse deterrent…
Buprenorphine, so misunderstood
Endo Pharmaceuticals recently announced the availability of Belbuca, the first buccal formulation of buprenorphine FDA approved for pain. Belbuca is…
Breaking Bad 2.0: Is it possible to synthesize Oxycodone from Naloxone?
Or perhaps a conversion to Oxymorphone is plausible. The answer, NOT LIKELY! But, this is surely another reason to allow…
Comparing Gabapentin to Pregabalin for Neuropathic Pain
Because of popular demand, Dr. Morganson and I decided to make this important post available to PainDr.com blog followers.…
Seedy Sea or CDC?
Perhaps the Seedy Sea storm is past, the weather is clearing, and the CDC will arise once again as a…
Unique Levorphanol Dodges Move from Forgotten to Vanished
Both Ms. Uyen (Wendy) Nguyen and Dr. Sparkes, as they appear below, deserve some heartfelt kudos for writing and helping…
Two Puffs Too Bad: Demystifying Marijuana Urine Testing
MJ, a 40 years old female, presents to your pain clinic for a routine follow-up visit. You decide to run…
Pharmacists, Physicians, and Industry Capriciously Targeted for Lawsuits
Be certain your liability insurance is paid in full and your assets are well-protected because as one perspicacious attorney put…
SEX, [pain] DRUGS, and ROCK & ROLL
Although a focus of pain management is to improve functionality and quality of life, and choice of regimens can be…